Earth Science Tech Inc. (OTC: ETST) recently released its fiscal year 2026 results for the year ended March 31, 2026, showcasing growth across key financial metrics as it continues to execute its diversified holdings model spanning healthcare, pharmaceuticals, telemedicine, real estate, and consumer businesses. The company reported an 8% increase in revenue to $35.7 million, gross profit rising 5% to $25.5 million, net income growing 11% to $3.6 million, and total assets increasing 27% to $9 million.
CEO Giorgio R. Saumat attributed the results to ETST’s efforts to fully integrate the patient experience across its platform, from telemedicine to pharmacy to fulfillment. According to the company, the core of its value proposition is the seamless integration of patient care, achieved through the synergy of specialized subsidiaries. Earth Science Tech operates as a diversified holding company focused on the health and wellness sector, with a principal operating strategy to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment.
The company's healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business. This integration is designed to provide a comprehensive solution that connects patients with healthcare providers, prescription filling, and delivery services. The results highlight the company's ability to grow despite a challenging economic environment, driven by its focus on operational efficiency and strategic expansion.
For more information, visit www.EarthScienceTech.com. The latest news and updates relating to ETST are available in the company’s newsroom at https://nnw.fm/ETST.
